NEO

NEO

USD

NeoGenomics Inc. Common Stock

$10.080-0.120 (-1.176%)

Real-time Price

Healthcare
Diagnostics & Research
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$10.200

High

$10.317

Low

$9.780

Volume

2.66M

Company Fundamentals

Market Cap

1.3B

Industry

Diagnostics & Research

Country

United States

Trading Stats

Avg Volume

3.47M

Exchange

NCM

Currency

USD

52-Week Range

Low $4.72Current $10.080High $19.11

Related News

BusinessWire

NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

Additional presentations to focus on liquid biopsy– MRD based detection and genomic profiling across solid tumors NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable

View more
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
BusinessWire

NeoGenomics Reports Third Quarter 2025 Results

Third quarter total revenue increased 12% YoY to $188 million Clinical revenue grew 18%, or 15% excluding the Pathline acquisition NGS revenue increased 24% YoY and now accounts for nearly one-third of clinical

View more
NeoGenomics Reports Third Quarter 2025 Results
BusinessWire

NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the presentation of assay-relevant data, including interventional therapy trials in

View more
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025